首页>
外国专利>
PROTEIN TYROSINE KINASE INHIBITOR FOR SUPPRESSION OF PROLIFERATION PROCESS IN MAMMAL CELL, CONTAINING BENZYLIDENE-AND CINNAMYLIDENE-MALONIC NITRILE DERIVATIVE AS ACTIVE INGREDIENT
PROTEIN TYROSINE KINASE INHIBITOR FOR SUPPRESSION OF PROLIFERATION PROCESS IN MAMMAL CELL, CONTAINING BENZYLIDENE-AND CINNAMYLIDENE-MALONIC NITRILE DERIVATIVE AS ACTIVE INGREDIENT
PROBLEM TO BE SOLVED: To obtain the subject medicine capable of specifically preventing cell growth in mammals by including a substituted benzylidene and a cinnamylidene-malonic acid derivative. SOLUTION: This medicine contains a compound represented by the formula (R1 and R2 are each CN, CONH2 , COOH, etc.; R3 is H, CH3 or OH; R4 to R7 are each H, OH, a 1-5C alkyl, a 1-5C alkoxy, NH2 , CHO, a halogen, NO2 , COOH, etc.) or its salt as an active ingredient. The compound of the formula includes e.g. 3,5-dihydroxybenzylidene-malonic nitrile. The medicine can be prepared in oral, rectal or parenteral form. The daily dose of the medicine is 10 mg to 10 g/adult. The compound of the formula can readily be available and has relatively simple structure and has no adverse effect.
展开▼
机译:解决的问题:通过包含取代的亚苄基和肉桂亚基-丙二酸衍生物,获得能够特异性地防止哺乳动物细胞生长的主题药物。溶液:该药物包含由下式表示的化合物:(R 1和R 2分别为CN,CONH2,COOH等; R 3为H,CH3或OH; R 4至R < 7>分别为H,OH,1-5C的烷基,1-5C的烷氧基,NH 2,CHO,卤素,NO 2,COOH等)或其盐作为有效成分。式的化合物包括例如3,5-二羟基亚苄基-丙二腈。该药物可以口服,直肠或肠胃外形式制备。该药物的日剂量为10毫克至10克/成人。该式的化合物可以容易地获得并且具有相对简单的结构并且没有不利影响。
展开▼